Navigation Links
Bio-Post and Washer System

ProductsBio-Post and Washer System
Company Arthrex
Item Bio-Post and Washer System
Features 
  • Bioabsorbable PLLA screw post and washer
  • Low profile spiked and smooth washer options
  • Exceptional shear and pull-out strength
  • Ideal for ACL, collateral ligament or posterolateral reconstruction
  • Description The Bio-Post and Washer System offers a bioabsorbable PLLA screw post for suture or soft tissue fixation in ligament repair or reconstruction. The tapered 35 mm length and cancellous screw design provide maximum fixation in cortical and cancellous bone. Ideal screw length can be intraoperatively determined and the screw cut to length with a Rongeur if necessary. Each sterile screw comes with a 16 mm diameter smooth and spiked washer option that can be snapped onto the screw head to maintain an elevated washer position during screw insertion. The three-pronged driver maximizes insertion torque strength and alleviates stripping. A pilot hole is predrilled and decorticated prior to screw insertion. The smooth, concave-shaped washer option is used to securely trap attached sutures and bulky suture knots atraumatically under the low profile washer to eliminate potential soft tissue irritation. The spiked washer option facilitates direct soft tissue or ligament fixation to bone. Bio-Post fixation strength exceeds 1000 Newtons in pull-out force testing.
    Info Arthrex
    Customer Service: (800) 933-7001
    Web site: http://www.arthrex.com

    Related medicine products :

    1. Dade DAC II Automated Cell Washer
    2. MW 96 Microplate Washer
    3. Microplate Washers - ELx50 96-/384-Well Auto Strip Washer
    4. Microplate Washers - ELx405 Microplate Washer
    5. Microplate Washers - EL401 Manual Washer
    6. Microplate ELISA Washers - Manual Microplate Washer
    7. Microplate ELISA Washers - Automated Microplate Washer
    8. PW 40 Microplate Washers
    9. PW 41 Microplate Washers
    10. Model 1575 Immunowash Microplate Washer
    11. Model 1575 Microplate Washer
    Microalbumin Linearity Control...
    Total IgE Control...
    The K-ASSAY Lipid Controls are assayed controls produced from fresh human sera to monitor the accuracy and precision of quantitative lipid determinations of human sera specimens....
    The K-ASSAY hs-CRP Control Set is intended to be used as a consistent test sample of known concentrations for monitoring the performance of hs-CRP (high sensitive C-Reactive Protein) immunoturbimetri...
    Medicine Products:
    (Date:8/1/2014)... use among young people has spiked, with 29.3 percent ... at least once and 17 percent admitting to regular use ... ‘Yes to Life,’ volunteers from the Church of Scientology of ... information about drugs, to help reverse this alarming trend. , ... Say ‘Yes’ to Life,” volunteers have distributed 40,000 copies of ...
    (Date:8/1/2014)... appetite and whole-body metabolism. A protein known as PPARγ ... and body weight, but the identity of the neurons ... new study in the Journal of Clinical Investigation ... neuron known as pro-opiomelanocortin (POMC) neurons is critical in ... and colleagues at Yale University School of Medicine found ...
    (Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- The U.S. ... approved a new drug, Jardiance, to help fight type ... alone or added to existing treatment regimens to control ... Dr. Curtis Rosebraugh, director of the Office of Drug ... and Research, said in an agency statement. The ...
    (Date:8/1/2014)... Summer is here, and with it comes the season of ... can be a pain for dogs. Animal Emergency & Referral ... get rid of ticks and prevent them completely. , Female ... which is why they are so active during this season. ... and carry a number of diseases, including lyme disease, babesiosis ...
    (Date:8/1/2014)... of a cancer diagnosis may improve health outcomes for ... by a researcher at the University of Houston (UH). ... intervention is the writing instruction. Otherwise, writing is just ... journal can be therapeutic, but oftentimes we don,t get ... not," said Qian Lu, assistant professor and director of ...
    Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:Tis the Season for Tick Prevention 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3
    ... Core Administration Software with ... PLANO, Texas, May 15 Perot Systems (NYSE:,PER) ... Core,Administration Software. Xcelys 5.0 software is a continuance of ... health plan market., Xcelys, formerly called PERADIGM software, ...
    ... of shingles cases, expert says , , THURSDAY, May ... older should be vaccinated against shingles, a condition that ... Disease Control and Prevention recommended on Thursday. , This ... 2006, after the ZOSTAVAX vaccine was approved by the ...
    ... pump inhibitors (PPIs) to control gastroesophageal reflux disease ... take them continue to experience breakthrough, which is ... regurgitation and heartburn. These breakthrough symptoms lead more ... (OTC) remedies, according to a survey recently conducted ...
    ... YORK, May 15 Pharmaceutical research and,development (R&D) is ... years and,a billion dollars of investment to turn a ... journey from discovery to market, is filled,with challenges. For ... makes it to the market. "From Molecule to Medicine," ...
    ... that,the U.S. Court of Appeals for the Federal Circuit ... District Court for the Central District of,California in the ... As a result of the Court of Appeals, ruling, ... Sanofi-aventis is considering all its legal options., While ...
    ... Diabetes,Wholesale (ADW), a discount provider of diabetic supplies, is ... network. ADW hopes to,expand its online reach and strengthen ... affiliate partners a percentage of every sale they refer.,Commissions ... our affiliate,program as a great way to cultivate an ...
    Cached Medicine News:Health News:Perot Systems Announces the Launch of Xcelys(TM) 5.0 Software 2Health News:CDC Recommends Shingles Vaccine for Those Over 60 2Health News:CDC Recommends Shingles Vaccine for Those Over 60 3Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 2Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 3Health News:District Court Decision Affirmed in U.S. Lovenox(R) (enoxaparin sodium) Patent Infringement Case 2Health News:American Diabetes Wholesale Launches Affiliate Program 2
    (Date:8/1/2014)... Calif. , Aug. 1, 2014  Isis Pharmaceuticals, ... initiation of a pivotal Phase 3 study evaluating ISIS-SMN ... the most common genetic cause of infant mortality. Isis ... within the next few weeks, at which time Isis ... development partner, Biogen Idec. The Phase 3 study, ENDEAR, ...
    (Date:8/1/2014)... Aug. 1, 2014 Inovio Pharmaceuticals, Inc. (NYSE ... conference call to report its second quarter 2014 financial ... ET. CEO Dr. J. Joseph Kim and ... earnings, provide a corporate update, and participate in a ... development plans for VGX-3100, Inovio,s immune therapy targeting pre-cancers ...
    (Date:8/1/2014)... Aug. 1, 2014 Arena Pharmaceuticals, Inc. ... corporate update and reported financial results for the ... "We have continued to see encouraging advancements ... 43% quarter-over-quarter increase in estimated total prescriptions and ... mark," said Jack Lief, Arena,s President and Chief ...
    Breaking Medicine Technology:Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11